Salustiano, Eduardo J.
Dumas, Matheus L.
Silva-Santos, Gabriel G.
Netto, Chaquip D.
Costa, Paulo R. R.
Rumjanek, Vivian M.
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Financiadora de Estudos e Projetos
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Fundação Ary Frauzino para Pesquisa e Controle do Câncer
Instituto Nacional de Ciência e Tecnologia para o Controle do Câncer
Article History
Received: 1 December 2015
Accepted: 11 May 2016
First Online: 18 May 2016
Compliance with ethical standards
:
: LQB-118, compounds of the pterocarpanquinone family, methods for preparing the same, pharmaceutical compositions containing new compounds of the pterocarpanquinone family, uses and therapeutic methods are protected under patent number US8835489B2, assigned to the Federal University of Rio de Janeiro and granted by USPTO in 16–09-2014 [CitationRef removed]. Eduardo J. Salustiano, Chaquip D. Netto, Paulo R. Costa and Vivian M. Rumjanek are listed as inventors. Patent was not outlicenced and inventors did not receive money from private companies but grants from public agencies stated in Acknowledgments. Funding agencies had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. Procedures for animal experimentation were approved by the Centro de Ciências da Saúde Ethics Committee for Animal Use (CEUA-CCS, UFRJ) under protocol number IBQM082.